© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 1, 24-33,
January 5, 2000
© 2000 Oxford University Press
Sex-Specific Expression of Gastrin-Releasing Peptide Receptor: Relationship to Smoking History and Risk of Lung Cancer
Affiliations of authors: S. P. Shriver, H. A. Bourdeau, C. T. Gubish, D. L. Tirpak, A. L. G. Davis, J. M. Siegfried (Department of Pharmacology), J. D. Luketich (Department of Surgery), Lung Cancer Program, University of Pittsburgh Cancer Institute, University of Pittsburgh, PA.
Correspondence to present address: Sharon Persinger Shriver, Ph.D., Department of Biology, The Pennsylvania State University, 208 Mueller Laboratory, University Park, PA 16802-5301 (e-mail: sps10{at}psu.edu).
Present address: D. L. Tirpak, Graduate School of Public Health, University of Texas Health Science Center, Houston.
BACKGROUND: Activation of gastrin-releasing peptide receptor (GRPR) in human airways has been associated with a proliferative response of bronchial cells to gastrin-releasing peptide and with long-term tobacco use. The GRPR gene is located on the X chromosome and escapes X-chromosome inactivation, which occurs in females. Increasing evidence demonstrates that women are more susceptible than men to tobacco carcinogenesis. We hypothesized that the susceptibility of women to the effects of tobacco may be associated with airway expression of GRPR. METHODS: We analyzed GRPR messenger RNA (mRNA) expression in lung tissues and cultured airway cells from 78 individuals (40 males and 38 females) and in lung fibroblasts exposed to nicotine in vitro. Nicotinic acetylcholine receptors in airway cells were assayed by use of radioactively labeled nicotine and nicotine antagonists. A polymorphism in exon 2 of the GRPR gene was used to detect allele-specific GRPR mRNA expression in some individuals. Statistical tests were two-sided. RESULTS: GRPR mRNA expression was detected in airway cells and tissues of more female than male nonsmokers (55% versus 0%) and short-term smokers (1-25 pack-years [pack-years = number of packs of cigarettes smoked per day multiplied by the number of years of smoking]) (75% versus 20%) (P = .018 for nonsmoking and short-term smoking females versus nonsmoking and short-term smoking males). Female smokers exhibited expression of GRPR mRNA at a lower mean pack-year exposure than male smokers (37.4 pack-years versus 56.3 pack-years; P = .037). Lung fibroblasts and bronchial epithelial cells exhibited high-affinity, saturable nicotinic acetylcholine-binding sites. Expression of GRPR mRNA in lung fibroblasts was elevated following exposure to nicotine. CONCLUSIONS: Our results suggest that the GRPR gene is expressed more frequently in women than in men in the absence of smoking and that expression of this gene is activated earlier in women in response to tobacco exposure. The presence of two expressed copies of the GRPR gene in females may be a factor in the increased susceptibility of women to tobacco-induced lung cancer.
This article has been cited by other articles:
![]() |
C. M. Tammemagi, M. T. Freedman, T. R. Church, M. M. Oken, W. G. Hocking, P. A. Kvale, P. Hu, T. L. Riley, L. R. Ragard, P. C. Prorok, et al. Factors Associated with Human Small Aggressive Non Small Cell Lung Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
International Early Lung Cancer Action Program Inv Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancer JAMA, July 12, 2006; 296(2): 180 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Loganathan, D. E. Stover, W. Shi, and E. Venkatraman Prevalence of COPD in Women Compared to Men Around the Time of Diagnosis of Primary Lung Cancer Chest, May 1, 2006; 129(5): 1305 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Ganti, A. E. Sahmoun, A. W. Panwalkar, K. K. Tendulkar, and A. Potti Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer J. Clin. Oncol., January 1, 2006; 24(1): 59 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thomas, L. A. Doyle, and M. J. Edelman Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy Chest, July 1, 2005; 128(1): 370 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Patel Lung Cancer in Women J. Clin. Oncol., May 10, 2005; 23(14): 3212 - 3218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Potosky, W. W. Davis, R. M. Hoffman, J. L. Stanford, R. A. Stephenson, D. F. Penson, and L. C. Harlan Five-Year Outcomes After Prostatectomy or Radiotherapy for Prostate Cancer: The Prostate Cancer Outcomes Study J Natl Cancer Inst, September 15, 2004; 96(18): 1358 - 1367. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Olak and Y. Colson Gender differences in lung cancer: Have we really come a long way, baby? J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 346 - 351. [Full Text] [PDF] |
||||
![]() |
W. J. Blot and J. K. McLaughlin Are Women More Susceptible to Lung Cancer? J Natl Cancer Inst, June 2, 2004; 96(11): 812 - 813. [Full Text] [PDF] |
||||
![]() |
C. Bain, D. Feskanich, F. E. Speizer, M. Thun, E. Hertzmark, B. A. Rosner, and G. A. Colditz Lung Cancer Rates in Men and Women With Comparable Histories of Smoking J Natl Cancer Inst, June 2, 2004; 96(11): 826 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Patel, P. B. Bach, and M. G. Kris Lung Cancer in US Women: A Contemporary Epidemic JAMA, April 14, 2004; 291(14): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
K M Fong, Y Sekido, A F Gazdar, and J D Minna Lung cancer * 9: Molecular biology of lung cancer: clinical implications Thorax, October 1, 2003; 58(10): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Duell, E. A. Holly, P. M. Bracci, J. K. Wiencke, and K. T. Kelsey A Population-based Study of the Arg399Gln Polymorphism in X-Ray Repair Cross- Complementing Group 1 (XRCC1) and Risk of Pancreatic Adenocarcinoma Cancer Res., August 15, 2002; 62(16): 4630 - 4636. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Wong, W. K. Lam, E. Wang, S. W. Chiu, C. L. Lam, and L. P. Chung Primary Adenocarcinomas of the Lung in Nonsmokers Show a Distinct Pattern of Allelic Imbalance Cancer Res., August 1, 2002; 62(15): 4464 - 4468. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Radzikowska, P. Glaz, and K. Roszkowski Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases Ann. Onc., July 1, 2002; 13(7): 1087 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Stabile, A. L. G. Davis, C. T. Gubish, T. M. Hopkins, J. D. Luketich, N. Christie, S. Finkelstein, and J. M. Siegfried Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor {alpha} and {beta} and Show Biological Responses to Estrogen Cancer Res., April 1, 2002; 62(7): 2141 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Lango, K. F. Dyer, V. W. Y. Lui, W. E. Gooding, C. Gubish, J. M. Siegfried, and J. R. Grandis Gastrin-Releasing Peptide Receptor-Mediated Autocrine Growth in Squamous Cell Carcinoma of the Head and Neck J Natl Cancer Inst, March 6, 2002; 94(5): 375 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haugen Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, February 1, 2002; 23(2): 227 - 229. [Full Text] [PDF] |
||||
![]() |
M. D. Lockshin Genome and Hormones: Gender Differences in Physiology: Invited Review: Sex ratio and rheumatic disease J Appl Physiol, November 1, 2001; 91(5): 2366 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Castelao, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, M. Gago-Dominguez, J. S. Crowder, R. K. Ross, and M. C. Yu Gender- and Smoking-Related Bladder Cancer Risk J Natl Cancer Inst, April 4, 2001; 93(7): 538 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Qingyi Wei, Lie Cheng, C. I. Amos, L.-E. Wang, Zhaozheng Guo, W. K. Hong, and M. R. Spitz Repair of Tobacco Carcinogen-Induced DNA Adducts and Lung Cancer Risk: a Molecular Epidemiologic Study J Natl Cancer Inst, November 1, 2000; 92(21): 1764 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Thun, E. E. Calle, C. Rodriguez, and P. A. Wingo Epidemiological Research at the American Cancer Society Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 861 - 868. [Full Text] |
||||










